Onderneming Ligand Pharmaceuticals Inc. OTC Bulletin Board
Aandelen
US53220K1815
Farmaceutische producten
slotkoers
Andere beurzen
|
||
- USD | - |
|
Vakgebied
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Biopharmaceutical
100,0
%
| 196 | 100,0 % | 131 | 100,0 % | -33,09% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 196 | 100,0 % | 131 | 100,0 % | -33,09% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Todd Davis
CEO | Chief Executive Officer | 63 | 01-03-07 |
Octavio Espinoza
DFI | Director of Finance/CFO | 53 | 01-11-22 |
President | 49 | 06-08-15 | |
Andrew Reardon
LAW | General Counsel | 49 | 01-01-22 |
Corporate Officer/Principal | - | 20/02 | |
Karen Reeves
PRN | Corporate Officer/Principal | - | 20/02 |
Human Resources Officer | - | 01-12-94 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
John Kozarich
CHM | Chairman | 74 | 01-03-03 |
John LaMattina
BRD | Director/Board Member | 74 | 01-02-11 |
Stephen Sabba
BRD | Director/Board Member | 64 | 04-08-08 |
Jason Aryeh
BRD | Director/Board Member | 55 | 27-09-06 |
Todd Davis
CEO | Chief Executive Officer | 63 | 01-03-07 |
Nancy Gray
BRD | Director/Board Member | 64 | 18-08-17 |
Director/Board Member | 55 | 26-09-23 | |
Jason Haas
BRD | Director/Board Member | 56 | 29-06-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 17 963 653 | 17 542 250 ( 97,65 %) | 0 | 97,65 % |
Participaties
Naam | Aandelen | % | Totale waarde |
---|---|---|---|
3 616 077 | 3.28% | 225 136 954 $ |
Bedrijfsgegevens
Ligand Pharmaceuticals, Inc.
555 Heritage Drive Suite 200
33458, Jupiter
+858 550 7500
http://www.ligand.com![Adres Ligand Pharmaceuticals Inc.](https://cdn.zonebourse.com/static/address/5981444.png)
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+56,83% | 815 mld. | |
+43,90% | 641 mld. | |
-6,81% | 352 mld. | |
+17,54% | 314 mld. | |
+9,45% | 303 mld. | |
+16,08% | 242 mld. | |
+2,29% | 224 mld. | |
+13,96% | 218 mld. | |
+8,05% | 168 mld. |
- Beurs
- Aandelen
- Koers LGND
- Koers
- Onderneming Ligand Pharmaceuticals Inc.